Literature DB >> 22224598

Allostery and the Monod-Wyman-Changeux model after 50 years.

Jean-Pierre Changeux1.   

Abstract

The Monod-Wyman-Changeux (MWC) model was conceived in 1965 to account for the signal transduction and cooperative properties of bacterial regulatory enzymes and hemoglobin. It was soon extended to pharmacological receptors for neurotransmitters and other macromolecular entities involved in intracellular and intercellular communications. Five decades later, the two main hypotheses of the model are reexamined on the basis of a variety of regulatory proteins with known X-ray structures: (a) Regulatory proteins possess an oligomeric structure with symmetry properties, and (b) the allosteric interactions between topographically distinct sites are mediated by a conformational transition established between a few preestablished states with conservation of symmetry and ligand-directed conformational selection. Several well-documented examples are adequately represented by the MWC model, yet a few possible exceptions are noted. New questions are raised concerning the dynamics of the allosteric transitions and more complex supramolecular ensembles.

Mesh:

Substances:

Year:  2012        PMID: 22224598     DOI: 10.1146/annurev-biophys-050511-102222

Source DB:  PubMed          Journal:  Annu Rev Biophys        ISSN: 1936-122X            Impact factor:   12.981


  136 in total

1.  Allostery vs. "allokairy".

Authors:  Vincent J Hilser; Jeremy A Anderson; Hesam N Motlagh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

2.  Population Distributions from Native Mass Spectrometry Titrations Reveal Nearest-Neighbor Cooperativity in the Ring-Shaped Oligomeric Protein TRAP.

Authors:  Melody L Holmquist; Elihu C Ihms; Paul Gollnick; Vicki H Wysocki; Mark P Foster
Journal:  Biochemistry       Date:  2020-06-26       Impact factor: 3.162

Review 3.  Substrate tunnels in enzymes: structure-function relationships and computational methodology.

Authors:  Laura J Kingsley; Markus A Lill
Journal:  Proteins       Date:  2015-02-28

Review 4.  The concept of allosteric interaction and its consequences for the chemistry of the brain.

Authors:  Jean-Pierre Changeux
Journal:  J Biol Chem       Date:  2013-07-22       Impact factor: 5.157

5.  How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function.

Authors:  Lisandro H Otero; Alzoray Rojas-Altuve; Leticia I Llarrull; Cesar Carrasco-López; Malika Kumarasiri; Elena Lastochkin; Jennifer Fishovitz; Matthew Dawley; Dusan Hesek; Mijoon Lee; Jarrod W Johnson; Jed F Fisher; Mayland Chang; Shahriar Mobashery; Juan A Hermoso
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-01       Impact factor: 11.205

Review 6.  50 years of allosteric interactions: the twists and turns of the models.

Authors:  Jean-Pierre Changeux
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-23       Impact factor: 94.444

7.  Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner.

Authors:  Anne Katchy; Caroline Pinto; Philip Jonsson; Trang Nguyen-Vu; Marchela Pandelova; Anne Riu; Karl-Werner Schramm; Daniel Samarov; Jan-Åke Gustafsson; Maria Bondesson; Cecilia Williams
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

Review 8.  The Allosteric Site for the Nascent Cell Wall in Penicillin-Binding Protein 2a: An Achilles' Heel of Methicillin-Resistant Staphylococcus aureus.

Authors:  Iván Acebrón; Mayland Chang; Shahriar Mobashery; Juan A Hermoso
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 9.  A gating mechanism of pentameric ligand-gated ion channels.

Authors:  Nicolas Calimet; Manuel Simoes; Jean-Pierre Changeux; Martin Karplus; Antoine Taly; Marco Cecchini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Statistical mechanics of Monod-Wyman-Changeux (MWC) models.

Authors:  Sarah Marzen; Hernan G Garcia; Rob Phillips
Journal:  J Mol Biol       Date:  2013-03-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.